A CLINICO-COMPARATIVE STUDY OF KAISORA GUGGULU WITH MANJISTHADI KVATHA AND EKAVINSATIKO GUGGULU WITH NISADI KVATHA IN THE MANAGEMENT OF PSORIASIS
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- To observe and find out changes in signs and symptoms of psoriasis after the oral administration of above mentioned medicinnes
Study Overview
Brief Summary
Psoriasis is a complex, chronic, multifactorial, inflammatory disease that
involves hyper proliferation of keratinocytes in the epidermis, with an
increase in the epidermal cell turnover rate. 20 patient of psoriasis who
fulfill the inclusion criteria will be selected from opd and give them oral
administration of khadirastak kwatha 40 ml twice a day and manjisthadi
taila for local application twice a day. Patient will be treated for 8 weeks.
Patients will be assessed before and after the treatment.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Masking
- Participant Blinded
Eligibility Criteria
- Ages
- 16.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Who fulfilled the diagnostic criteria mentioned as sign and symptom Any three of these symptoms 1.Scaling 2.Itching (Kandu) 3.Erythema 4.Loss of perspiration 5.Dryness Any one of these signs 1.Auspitz sign 2.Candle grease sign 3.Koebners phenomenon Patients of age between 18 to 60 years and of both genders.
Exclusion Criteria
- •Pregnant or lactating females.
- •1.Known cases of diseases like AIDS, STD, TB, heart diseases and other disorders that lead to fetal conditions for the patients.
- •2.Patients having diabetes mellitus.
- •3.Other concomitant skin diseases occurring with the allergic reaction of any other disease.
Outcomes
Primary Outcomes
To observe and find out changes in signs and symptoms of psoriasis after the oral administration of above mentioned medicinnes
Time Frame: A patient will be treated at O.P.D. level for 8 weeks of treatment. They will be instructed to visit the hospital every 2 weeks at intervals.
Secondary Outcomes
- To evaluate the changes in the PASI index in the patients of psoriasis.(2.To find out the improvement in quality of life through changes in DLQI in the patients of psoriasis.)
Investigators
Dr Manali Chauhan
J.S Ayurveda